Viking Therapeutics (VKTX) Misses Q2 EPS by 2c
Get Alerts VKTX Hot Sheet
Join SI Premium – FREE
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Acme United (ACU) Misses Q1 EPS by 20c
- Oilfield firm SLB's profit rises on international drilling demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!